NCT00236639View on ClinicalTrials.gov

A Study on Efficacy and Safety of Topiramate in the Treatment of Patients With Obesity

PHASE3CompletedINTERVENTIONAL
Enrollment

1,293

Participants

Timeline

Start Date

July 31, 2000

Study Completion Date

June 30, 2002

Conditions
Obesity
Interventions
DRUG

topiramate

All Listed Sponsors
lead

Johnson & Johnson Pharmaceutical Research & Development, L.L.C.

INDUSTRY

NCT00236639 - A Study on Efficacy and Safety of Topiramate in the Treatment of Patients With Obesity | Biotech Hunter | Biotech Hunter